Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Elevance Health, Inc. Director's Dealing 2012

May 18, 2012

29933_dirs_2012-05-18_ab67b1c3-9a88-40c2-8429-05af3a34fe74.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WELLPOINT, INC (WLP)
CIK: 0001156039
Period of Report: 2012-05-16

Reporting Person: BURKE SHEILA P (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-05-16 Phantom Stock Units $ A 2681 Acquired Common Stock (2681) Direct

Footnotes

F1: The phantom stock units were accrued under the WellPoint, Inc. ("Company") Board of Directors Deferred Compensation Plan ("the "Plan").

F2: The Conversion or Exercise Price of the Derivative Security is 1-for-1.

F3: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Plan in accordance with the terms of the Plan.